CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 144 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $873,000 | +2.9% | 241,699 | +0.8% | 0.23% | -27.9% |
| Q4 2016 | $848,000 | -83.1% | 239,662 | -80.7% | 0.32% | -79.0% |
| Q3 2016 | $5,022,000 | -9.5% | 1,243,164 | -1.7% | 1.52% | -19.9% |
| Q2 2016 | $5,550,000 | +48.4% | 1,264,227 | +27.8% | 1.90% | +39.6% |
| Q1 2016 | $3,740,000 | -62.6% | 989,376 | +55.3% | 1.36% | -58.8% |
| Q4 2015 | $9,992,000 | +31.9% | 637,238 | -11.3% | 3.30% | +40.2% |
| Q3 2015 | $7,575,000 | -36.3% | 718,729 | +52.4% | 2.35% | -32.0% |
| Q2 2015 | $11,893,000 | – | 471,554 | – | 3.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
| Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
| TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
| GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
| Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
| Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
| Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
| LMR Partners LLP | 408,846 | $206,000 | 0.01% |